FDA begins reviewing the status of Oxygen mfg and refilling plants

“FDA officials will visit the manufacturers, re-fillers and air-separation units of private ownerships for inspections.


Last Updated on January 14, 2022 by The Health Master

NAGPUR: The Food and Drugs Administration (FDA) has started reviewing the current status of oxygen manufacturing and refilling plants at 12 privately-owned premises to gage their preparedness with the Omicron threat looming large in the region.

It’s learnt that a three-day statewide inspection has been undertaken by FDA authorities under the supervision of commissioner Parimal Singh.

The objective behind the exercise is to ensure that the plants are ready to cater to the supply needs of medical oxygen if demand suddenly rises due to increasing patient numbers.

In the last two waves, especially the second, an acute shortage of oxygen was felt across the state. In Nagpur, oxygen had to be brought from other states in oxygen-special trains and Indian Air Force (IAF) load carriers.

During emergencies, some oxygen plants faced technical snags too, leading to disruptions in supply as the healthcare system was crumbling under the demands of oxygenated beds.

FDA assistant commissioner PM Ballal said liquid medical oxygen manufacturers like Inox Air Products at Butibori were being inspected to ascertain their current production capacity, fitness of plant machineries, storage capacities and such parameters which are crucial for their functioning and delivering ability during peak requirement.

“FDA officials will visit the manufacturers, re-fillers and air-separation units of private ownerships for inspections.

The reports will be forwarded to the Mumbai FDA head office for statewide review,” said Ballal, adding that joint commissioner Viraj Paunikar is co-ordinating the oxygen plant audits in Vidarbha region.

Apart from Butibori, FDA officials will also visit the key players in oxygen production like Aditya Air Products at Hingna, Aassi Cryogenic Private Limited at Butibori and Jagadamba Gases at Mauda.

It’s learnt that the civil surgeon and district health officer are conducting similar oxygen plant audits at government premises like medical colleges, AIIMS, rural health centers, and hospitals.

FDA raids 16 Medical Stores for violation of D&C Rules

Indian Pharma Firms get 210 out of 635 approvals from USFDA

USFDA gives tentative nod to Alembic for Dronedarone tablets

Confusion over Molnupiravir ? Let’s understand

DCGI raises alarm over suspected spurious Tocilizumab injections in India

Drug recall: Clobetasol Propionate Ointment recalled due to this reason

3rd booster shot of Covaxin shows positive responses

FDA asks Chemists and Hospitals to ramp up medicine supply

India to become hub for Covid-19 antiviral medicines

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner